STSA logo

Satsuma Pharmaceuticals (STSA) EBIT

STSA Annual EBIT

-$70.04 M
-$19.03 M-37.31%

31 December 2022

STSA EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

STSA Quarterly EBIT

-$10.29 M
+$12.84 M+55.50%

31 March 2023

STSA Quarterly EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

STSA TTM EBIT

-$64.83 M
+$5.21 M+7.44%

31 March 2023

STSA TTM EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

STSA EBIT Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-37.3%+33.6%-15.5%
3 y3 years-152.9%+12.0%-76.6%
5 y5 years-1258.2%-548.6%-134.1%

STSA EBIT High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year
5 y5-year
alltimeall time+1260.8%+548.6%+3985.1%

Satsuma Pharmaceuticals EBIT History

DateAnnualQuarterlyTTM
Mar 2023
-
-$10.29 M(-55.5%)
-$64.83 M(-7.4%)
Dec 2022
-$70.04 M(+37.3%)
-$23.13 M(+52.8%)
-$70.04 M(+12.2%)
Sept 2022
-
-$15.14 M(-6.9%)
-$62.44 M(+3.0%)
June 2022
-
-$16.27 M(+4.9%)
-$60.60 M(+8.0%)
Mar 2022
-
-$15.51 M(-0.1%)
-$56.12 M(+10.0%)
Dec 2021
-$51.01 M(+8.0%)
-$15.53 M(+16.8%)
-$51.01 M(+6.4%)
Sept 2021
-
-$13.30 M(+12.8%)
-$47.96 M(+2.5%)
June 2021
-
-$11.79 M(+13.3%)
-$46.77 M(+1.3%)
Mar 2021
-
-$10.40 M(-16.6%)
-$46.16 M(-2.7%)
Dec 2020
-$47.21 M
-$12.48 M(+3.0%)
-$47.46 M(+3.9%)
DateAnnualQuarterlyTTM
Sept 2020
-
-$12.11 M(+8.4%)
-$45.68 M(+9.5%)
June 2020
-
-$11.18 M(-4.5%)
-$41.71 M(+13.6%)
Mar 2020
-
-$11.70 M(+9.4%)
-$36.70 M(+32.5%)
Dec 2019
-$27.69 M(+281.7%)
-$10.69 M(+31.4%)
-$27.69 M(+43.8%)
Sept 2019
-
-$8.14 M(+31.9%)
-$19.26 M(+51.6%)
June 2019
-
-$6.17 M(+129.1%)
-$12.71 M(+94.4%)
Mar 2019
-
-$2.69 M(+19.4%)
-$6.54 M(+70.1%)
Dec 2018
-$7.26 M(+40.7%)
-$2.26 M(+42.2%)
-$3.84 M(+142.2%)
Sept 2018
-
-$1.59 M
-$1.59 M
Dec 2017
-$5.16 M
-
-

FAQ

  • What is Satsuma Pharmaceuticals annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Satsuma Pharmaceuticals?
  • What is Satsuma Pharmaceuticals annual EBIT year-on-year change?
  • What is Satsuma Pharmaceuticals quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Satsuma Pharmaceuticals?
  • What is Satsuma Pharmaceuticals quarterly EBIT year-on-year change?
  • What is Satsuma Pharmaceuticals TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Satsuma Pharmaceuticals?
  • What is Satsuma Pharmaceuticals TTM EBIT year-on-year change?

What is Satsuma Pharmaceuticals annual earnings before interest & taxes?

The current annual EBIT of STSA is -$70.04 M

What is the all time high annual EBIT for Satsuma Pharmaceuticals?

Satsuma Pharmaceuticals all-time high annual earnings before interest & taxes is -$5.15 M

What is Satsuma Pharmaceuticals annual EBIT year-on-year change?

Over the past year, STSA annual earnings before interest & taxes has changed by -$19.03 M (-37.31%)

What is Satsuma Pharmaceuticals quarterly earnings before interest & taxes?

The current quarterly EBIT of STSA is -$10.29 M

What is the all time high quarterly EBIT for Satsuma Pharmaceuticals?

Satsuma Pharmaceuticals all-time high quarterly earnings before interest & taxes is -$1.59 M

What is Satsuma Pharmaceuticals quarterly EBIT year-on-year change?

Over the past year, STSA quarterly earnings before interest & taxes has changed by +$5.21 M (+33.61%)

What is Satsuma Pharmaceuticals TTM earnings before interest & taxes?

The current TTM EBIT of STSA is -$64.83 M

What is the all time high TTM EBIT for Satsuma Pharmaceuticals?

Satsuma Pharmaceuticals all-time high TTM earnings before interest & taxes is -$1.59 M

What is Satsuma Pharmaceuticals TTM EBIT year-on-year change?

Over the past year, STSA TTM earnings before interest & taxes has changed by -$8.71 M (-15.53%)